Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Active not recruiting 2 Unknown 1 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

OTHER 1 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

Specimen Handling 7 Magnetic Resonance Spectroscopy 6 Radiotherapy 5 Biopsy 4 Radiation 3 Cytarabine 3 Cyclophosphamide 3 venetoclax 2 Vincristine 2 Standard of Care 2 Spinal Puncture 2 Practice Guidelines as Topic 2 High-Energy Shock Waves 2 Daunorubicin 2 Azacitidine 2 trastuzumab deruxtecan 1 trastuzumab biosimilar HLX02 1 taxane 1 sulforaphane 1 sacituzumab govitecan 1 revumenib 1 prednylidene 1 pertuzumab 1 pembrolizumab 1 pegaspargase 1 nelarabine 1 merphos 1 liposomal doxorubicin 1 lenvatinib 1 gilteritinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × NETWORK × Dasatinib × Clear all

NCT05944783 2025-02-12

BE-Dasatinib

Centro de Atencion e Investigacion Medica

Phase 4 Not yet recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡